These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6119719)

  • 21. Problems in therapeutic blood monitoring of chlorpromazine.
    Rivera-Calimlim L
    Ther Drug Monit; 1982; 4(1):41-9. PubMed ID: 7041337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M; Gouws E; Miller R; Moodley SV
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
    May PR; Van Putten T; Jenden DJ; Cho AK
    Arch Gen Psychiatry; 1978 Sep; 35(9):1091-7. PubMed ID: 686971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
    Meltzer HY; Busch D
    Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B; Alfredsson G
    Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma nor1-chlorpromazine concentrations: effects of age, race, and sex.
    Young RC
    Ther Drug Monit; 1986; 8(1):23-6. PubMed ID: 3961892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive indices for chlorpromazine therapy in schizophrenics.
    Dixon PA; Oforah E; Makanjuola R
    Br J Clin Pharmacol; 1982 Aug; 14(2):273-7. PubMed ID: 7104178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.
    Chetty M; Pillay VL; Moodley SV; Miller R
    Eur Neuropsychopharmacol; 1996 May; 6(2):85-91. PubMed ID: 8791032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.
    Sato H; Uematsu T; Yamada K; Nakashima M
    Eur J Clin Pharmacol; 1993; 44(5):439-44. PubMed ID: 8359180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.
    Stimmel GL; Falloon IR
    J Clin Psychiatry; 1983 Nov; 44(11):420-2. PubMed ID: 6643405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level.
    Sakalis G; Curry SH; Mould GP; Lader MH
    Clin Pharmacol Ther; 1972; 13(6):931-46. PubMed ID: 5081606
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma and saliva levels of chlorpromazine and subjective response.
    Van Putten T; May PR; Jenden DJ; Cho AK; Yale C
    Am J Psychiatry; 1980 Oct; 137(10):1241-2. PubMed ID: 7416274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1984; 84(2):237-41. PubMed ID: 6438683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lithium on plasma chlorpromazine levels.
    Rivera-Calimlim L; Kerzner B; Karch FE
    Clin Pharmacol Ther; 1978 Apr; 23(4):451-5. PubMed ID: 630793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Important metabolites to measure in pharmacodynamic studies of chlorpromazine.
    Chetty M; Moodley SV; Miller R
    Ther Drug Monit; 1994 Feb; 16(1):30-6. PubMed ID: 8160251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting outcome of antipsychotic drug treatment from early response.
    May PR; Van Putten T; Yale C
    Am J Psychiatry; 1980 Sep; 137(9):1088-9. PubMed ID: 7425161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.